Categories
Coronary artery bypass surgery in patients with menopause
From Wikidoc - Reading time: 3 min
|
Coronary Artery Bypass Surgery Microchapters | |
|
Pathophysiology | |
|---|---|
|
Diagnosis | |
|
Treatment | |
|
Perioperative Monitoring | |
|
Surgical Procedure | |
|
Special Scenarios | |
|
Coronary artery bypass surgery in patients with menopause On the Web | |
|
FDA on Coronary artery bypass surgery in patients with menopause | |
|
CDC on Coronary artery bypass surgery in patients with menopause | |
|
Coronary artery bypass surgery in patients with menopause in the news | |
|
Blogs on Coronary artery bypass surgery in patients with menopause|- |
|
|
Directions to Hospitals Performing Coronary artery bypass surgery in patients with menopause | |
|
Risk calculators for Coronary artery bypass surgery in patients with menopause | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (DO NOT EDIT)[1][edit | edit source]
Hormonal Manipulation (DO NOT EDIT)[1][edit | edit source]
| Class III: HARM |
| "1. Postmenopausal hormonal therapy (estrogen/progesterone) should not be administered to women undergoing CABG.[2][3][4] (Level of Evidence: B)" |
Sources[edit | edit source]
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.[1]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG; et al. (2011). "2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e31823c074e. PMID 22064599.
- ↑ Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998). "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group". JAMA : the Journal of the American Medical Association. 280 (7): 605–13. PMID 9718051. Retrieved 2011-12-14. Unknown parameter
|month=ignored (help) - ↑ Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002). "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial". JAMA : the Journal of the American Medical Association. 288 (3): 321–33. PMID 12117397. Retrieved 2011-12-14. Unknown parameter
|month=ignored (help) - ↑ Ouyang P, Tardif JC, Herrington DM, Stewart KJ, Thompson PD, Walsh MN, Bennett SK, Heldman AW, Tayback MA, Wang NY (2006). "Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries". Atherosclerosis. 189 (2): 375–86. doi:10.1016/j.atherosclerosis.2005.12.015. PMID 16442114. Retrieved 2011-12-14. Unknown parameter
|month=ignored (help)
EncycloReader
is supported by the 
KSF